Johanna Mylet serves as Executive at Poseida Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Johanna Mylet has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 1, 2024 involved selling 18,091 shares valued at $74.7K.
Johanna Mylet currently holds 246,283 shares of Poseida Therapeutics, Inc. (PSTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Johanna Mylet has been a net neutral trader of PSTX stock. They have purchased $0 and sold $0 worth of shares.
Johanna Mylet's most recent insider trade was on Mar 1, 2024, when they sold 18,091 shares at $4.13 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 1, 2023 | PSTX | $23.1K | Payment | 4,323 | $5.35 | Discretionary |
| Mar 1, 2023 | PSTX | $0 | Award | 92,772 | $N/A | Discretionary |
| Mar 1, 2022 | PSTX | $0 | Award | 50,000 | $N/A | Discretionary |
| Dec 21, 2021 | PSTX | $6.0K | Option Exercise | 3,100 | $1.93 | Discretionary |
| Dec 21, 2021 | PSTX | $3.1K | Option Exercise | 2,616 | $1.17 | Discretionary |
| Jan 15, 2021 | PSTX | $1.4K | Option Exercise | 4,728 | $0.30 | Discretionary |